Although additional studies with larger and more diverse populations and a functional analysis of the polymorphism are necessary to confirm and extend our findings, we believe that the Axin2 rs2240308 SNP could be a useful biomarker for the predisposition to prostate cancer and for the early diagnosis of the disease. This evidence concerns the gene AXIN2 and prostate cancer.